Amplify Weight Loss Drug & Treatment ETF (THNR) Short Interest Ratio & Short Volume

Short interest is the volume of Amplify Weight Loss Drug & Treatment ETF shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 100 shares of THNR short. Learn More on Amplify Weight Loss Drug & Treatment ETF's current short interest.

Amplify Weight Loss Drug & Treatment ETF saw a decrease in short interest in May. As of May 15th, there was short interest totaling 100 shares, a decrease of 50.0% from the previous total of 200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Amplify Weight Loss Drug & Treatment ETF: ProShares Decline of the Retail Store ETF (0.32%), Tema Luxury ETF (0.50%), ProShares Ultra Nasdaq Cloud Computing ETF (0.11%), iShares Breakthrough Environmental Solutions ETF (0.31%), SPDR MSCI USA Climate Paris Aligned ETF (0.25%), iShares Neuroscience and Healthcare ETF (8.13%), Global X Disruptive Materials ETF (0.82%), First Trust Nasdaq Lux Digital Health Solutions ETF (0.40%), and Gabelli Growth Innovators ETF (0.26%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

Short selling THNR is an investing strategy that aims to generate trading profit from Amplify Weight Loss Drug & Treatment ETF as its price is falling. THNR shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Amplify Weight Loss Drug & Treatment ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of THNR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including THNR, twice per month. The most recent reporting period available is May, 15 2025.